Xuejin Zhu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Antidiabetic medications and the risk of bladder cancer in patients with diabetes mellitus: A systematic review and meta-analysis.
Journal: Urologic oncology
Published: December 23, 2025
Aberrant activation of epigenetic BRD9-DGAT1 axis promotes lipid droplets deposition and ferroptosis resistance in YAP-high prostate cancer.
Journal: Cell death & disease
Published: June 27, 2025
Clinical outcomes of modified partial cystectomy in muscle-invasive bladder cancer: balancing tumor control and quality of life.
Journal: Translational andrology and urology
Published: March 31, 2025
Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation.
Journal: Cancer letters
Published: February 26, 2025
Multidimensional investigation of thyroid hormones and prostate cancer: insights from NHANES, Mendelian randomization, genetic markers, and bioinformatics analyses.
Journal: Discover oncology
Published: January 23, 2025
L-shaped association between the ratio of serum albumin to globulin and the risk of all-cause mortality among adults with kidney stones: a national cohort study.
Journal: Translational andrology and urology
Published: October 25, 2024
Machine learning-based integration develops a stress response stated T cell (Tstr)-related score for predicting outcomes in clear cell renal cell carcinoma.
Journal: International immunopharmacology
Published: January 01, 2024
Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin in selected patients with muscle-invasive bladder cancer: a real-world study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 17, 2023
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation.
Journal: Cell death & disease
Published: September 29, 2023
Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer.
Journal: Signal transduction and targeted therapy
Published: September 02, 2022
Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer.
Journal: Frontiers in cell and developmental biology
Published: December 08, 2021
EID3 Promotes Cancer Stem Cell-Like Phenotypes in Osteosarcoma through the Activation of PI3K-AKT Signaling Pathway.
Journal: Oxidative medicine and cellular longevity
Published: September 13, 2021
Last Updated: 09/26/2026